Empowering Women's Heart Health: Innovations and Insights in Cardiovascular Diagnostics

Published: 31.01.2024
04 Jan, 2024
Covid-19 Products Update

HyTest antibodies should recognize Pirola and Eris variants.

Read more
19 Dec, 2023
Launching recombinant procollagen type I N-propetide antigen: Advancing Bone Disease Awareness

Procollagen type I N-propetide (PINP) in blood is recommended as a reference marker for bone formation in osteoporosis by the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry (IFCC) bone marker standards joint working group. PINP, in particular, has emerged as a recommended reference marker for bone formation in osteoporosis, aiding in monitoring antiresorptive and anabolic therapies.

Read more
30 Nov, 2023
Call for Nominations: IFCC Distinguished Award for Contributions to Cardiovascular Diagnostics – Sponsored by HyTest

This distinguished award seeks to recognize and honours outstanding individuals who have made significant contributions to the field of Cardiovascular Diagnostics.

Read more
30 Nov, 2023
Role of HyTest in Cardiac Troponin Detection and Myocardial Infarction Diagnosis

At HyTest, our specialization in cardiac troponin (cTn) detection spans nearly three decades. Over the years, we have generated and analysed thousands of cTn-specific antibodies.

Read more
31 Oct, 2023
New Recombinant Human Cardiac Troponin Complex

We're delighted to announce the launch of our latest troponin product: the recombinant chimeric human Cardiac Troponin binary Complex (Cat. # 8IFC20). This unique complex features the most stable part of cTnI (fragment 28-110) linked with TnC by a 20-aar flexible linker of the cTn I – C complex.

Read more
27 Sep, 2023
Meet us at Medica 2023 in November

We will be attending Medica 2023 in November.

Read more
05 Jul, 2023
Hytest Appoints New CCO and General Manager of Hytest China

We have been privileged to have Soozy and Linda on our team for about 10 years. Now the story continues with new job descriptions – Soozy Xi will continue as CCO of HyTest and Linda Li will take on the role of General Manager of HyTest China. The whole team warmly congratulates! We also got a few comments from them:

Read more
05 Jul, 2023
Hytest Webinar: Clinical Applications of Procalcitonin (PCT) and Challenges in Measurement Standardization

Procalcitonin (PCT) is an established biomarker, which is used to guide antibiotic treatment in septic patient. As an invaluable indicator, it shows high sensitivity and specificity for bacterial infection. Given the utility of PCT in clinical setting, variability in results from different commercial assays have been observed. In this webinar, participants will have the opportunity to review the clinical application of PCT, technology used for PCT measurements and also the challenges in terms of the standardization effort.

Read more
20 Jun, 2023
Meet us at AACC Annual Scientific Meeting & Clinical Lab Expo in July

#teamhytest is looking forward to meeting our customers at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim!

Read more
13 Jun, 2023
Hut Coats Appointed as General Manager of Hytest North America

We are happy to introduce General Manager of HyTest North America Hut Coats. With Hut in our team, we’re able to be closer to our customers in North America and provide even better service.

Read more
01 Jun, 2023
The Winner of the Fourth EFLM-HyTest Cardiac Marker

The EFLM Award Committee had a difficult task in selecting for the most remarkable scientific work among the submitted papers but in the end Rami Aalto, (University of Turku, Finland) was selected to receive the award.

Read more
17 May, 2023
Hytest Appoints Netta Keinänen as New CEO

We are pleased to announce that Netta Keinänen, a valued member of our leadership team, will be stepping into the role of CEO on June 5th, 2023. With her experience, leadership, and strategic vision, we are confident that Netta will continue to lead us to even greater success.  

Read more
27 Apr, 2023
New Troponin Product Available

We have launched a new troponin MAb Y302 recombinant monoclonal antibody, which is expressed in a mammalian cell line and contains full-size IgG sequence derived from rabbit B cells and epitope specificity for this MAb is 83 – 100 a.a.r. of human cardiac troponin I.

Read more
30 Mar, 2023
New Article: Fragmentation of Human Cardiac Troponin T After Acute Myocardial Infarction

A new article titled "Fragmentation of human cardiac troponin T after acute myocardial infarction" by our scientists was published in Clinica Chimica Acta journal.

Read more
30 Mar, 2023
New Product: Recombinant Thyroglobulin

We are launching a new product, recombinant thyroglobulin, Cat # 8RTG4.

Read more
27 Jan, 2023
New Antibodies for Cardiac Troponin I

Troponin I and T are the main biomarkers and gold standards for diagnostics of acute myocardial infarction (AMI). Recently high- sensitivity cTn (hs-cTn) assays, the detection limit of which is pg/ml (ng/l) rather than ng/ml, have made it possible to identify any myocardial injury, including those AMI patients, within 1 to 3 hours. This represents a potential 3-hour time saving to ensure more rapid patient management.

Read more
25 Jan, 2023
New Antibodies for NT-proBNP

HF is a severe clinical and public health problem that is characterized by an increasing prevalence and economic cost. NT-proBNP, a derivative of pro-B-type natriuretic peptide (proBNP), is an established biomarker for heart failure (HF) diagnostics.

Read more
30 Nov, 2022
Meet our Team at Medlab Middle East 2023

We will be attending Medlab Middle East 2023 in the beginning of February.

Read more
30 Nov, 2022
Are you Prepared for the Busy Flu Season?

Seasonal flu is an acute respiratory infection caused by influenza viruses, including influenza A and influenza B. The typical symptoms include headaches, running nose, cough and muscle pain. The infection of other respiratory viruses, such as respiratory syncytial virus (RSV), can also present flu-like symptoms.

Read more

Do you need samples?

We are happy to make you an offer